Literature DB >> 11699055

Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.

Y J Lee1, J C Tsai.   

Abstract

To investigate the genetic susceptibility associated with cough related to angiotensin-converting enzyme inhibitor (ACEI) therapy in patients with type 2 diabetes, 189 non-insulin-dependent diabetes mellitus (NIDDM) patients with proteinuria or hypertension treated with perindopril were studied. Cough was considered to be present if the patients had been bothered by a cough during treatment and if they had had related symptoms for at least 2 weeks without an identifiable cause. Polymerase chain reaction (PCR) coupled with single-strand conformation polymorphism (SSCP) was used to detect polymorphisms of ACE and bradykinin B2-receptor genes. After 8 weeks of treatment, 49.2% (93 of 189) of our NIDDM patients were found to be suffering from ACEI-related cough. ACEI-related cough was mainly associated with female patients, with 71.7% (76 of 106) of female and only 20.5% (17 of 83) of male patients experiencing cough after ACEI treatment. There was a significant association of ACE II genotype with ACEI-related cough. The genotype frequencies were 58.2% for II, 47.8% for ID, and 16.7% for DD in patients with ACEI-associated cough and 41.8% for II, 52.2% for ID, and 83.3% for DD in subjects without ACEI-associated cough (chi(2) = 10.268; df = 2, P =.006). As female patients made up the majority of the subjects suffering from ACEI-related cough, we further analyzed the association of ACE I/D genotype with ACEI-related cough separately by sex. Male patients with ACEI-related cough were not associated with ACE I/D genotype distribution, while female patients were strongly associated with ACE I/D genotype polymorphism (chi(2) = 16.12; df = 2; P <.001). There was no association between the bradykinin B2 receptor gene -58T/C polymorphism with ACEI-related cough. In conclusion, our results indicate that Chinese diabetic female subjects are susceptible to ACEI-related cough, and this susceptibility may be genetically predetermined. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699055     DOI: 10.1053/meta.2001.27212

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis.

Authors:  Kazuaki Nishio; Shinji Kashiki; Hideaki Tachibana; Youichi Kobayashi
Journal:  World J Cardiol       Date:  2011-10-26

2.  eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril.

Authors:  P S Silva; V Fontana; M R Luizon; R Lacchini; W A Silva; C Biagi; J E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

3.  Efficacy and Safety of Olmesartan in the Treatment of Mild-to-Moderate Essential Hypertension in Chinese Patients.

Authors:  Chiau-Suong Liau; Chii-Ming Lee; Sheng-Hsiung Sheu; Kwo-Chang Ueng; Kuo-Liong Chien; Ta-Chen Su; Wen-Ter Lai; Ming-Cheng Lin; Cheng-Sheng Lin; Chung-Sheng Lin
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

4.  In a subgroup of high-risk Asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events.

Authors:  Antonio L Dans; Koon Teo; Peggy Gao; Jyh-Hong Chen; Kim Jae-Hyung; Khalid Yusoff; Suphachai Chaithiraphan; Jun Zhu; Liu Lisheng; Salim Yusuf
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

5.  Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.

Authors:  Giuseppe Mancia; Helmut Schumacher
Journal:  Patient Prefer Adherence       Date:  2011-12-23       Impact factor: 2.711

6.  Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.

Authors:  Ya-Feng Li; Xiao-Ming Zhu; Fan Liu; Chuan-Shi Xiao; Yun-Fei Bian; Hong Li; Jun Cai; Rong-Shan Li; Xin-Chun Yang
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

7.  A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.

Authors:  J D Mosley; C M Shaffer; S L Van Driest; P E Weeke; Q S Wells; J H Karnes; D R Velez Edwards; W-Q Wei; P L Teixeira; L Bastarache; D C Crawford; R Li; T A Manolio; E P Bottinger; C A McCarty; J G Linneman; M H Brilliant; J A Pacheco; W Thompson; R L Chisholm; G P Jarvik; D R Crosslin; D S Carrell; E Baldwin; J Ralston; E B Larson; J Grafton; A Scrol; H Jouni; I J Kullo; G Tromp; K M Borthwick; H Kuivaniemi; D J Carey; M D Ritchie; Y Bradford; S S Verma; C G Chute; A Veluchamy; M K Siddiqui; C N A Palmer; A Doney; S H MahmoudPour; A H Maitland-van der Zee; A D Morris; J C Denny; D M Roden
Journal:  Pharmacogenomics J       Date:  2015-07-14       Impact factor: 3.550

Review 8.  Drug-Induced Cough.

Authors:  J-S Shim; W-J Song; A H Morice
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

9.  The effect of bradykinin B2 receptor polymorphisms on the susceptibility and severity of osteoarthritis in a Chinese cohort.

Authors:  Shuo Chen; Yong Zhou; Jun Li; Le-Qun Shan; Qing-Yu Fan
Journal:  J Biomed Biotechnol       Date:  2012-10-03

10.  SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.

Authors:  Jian-Quan Luo; Fa-Zhong He; Zhen-Min Wang; Ning-Ling Sun; Lu-Yan Wang; Gen-Fu Tang; Mou-Ze Liu; Qing Li; Xiao-Ping Chen; Zhao-Qian Liu; Hong-Hao Zhou; Wei Zhang
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.